Kisato Nosaka
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
CD5-positive diffuse large B-Cell lymphoma presenting with protein-losing enteropathy.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: April 01, 2026
Recent progress in T-cell malignancies including adult T-cell leukemia-lymphoma.
Journal: International journal of hematology
Published: February 26, 2026
Prognostic impact of morphological lymphocyte counts on aggressive adult T-cell leukemia/lymphoma: Japan ATL nationwide registry analysis.
Journal: Blood cancer journal
Published: February 08, 2026
Efficacy of favipiravir treatment for patients with severe fever with thrombocytopenia syndrome assessed with a historical control.
Journal: Antimicrobial agents and chemotherapy
Published: October 17, 2025
Timing of autologous stem cell transplantation and induction response in central nervous system lymphoma.
Journal: International journal of hematology
Published: September 08, 2025
EBV-associated histological transformation of marginal zone lymphomas: two case reports and a literature review.
Journal: Virchows Archiv : an international journal of pathology
Published: August 22, 2025
Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.
Journal: British journal of haematology
Published: July 07, 2025
JunB-HBZ nuclear translocation by TGF-β is a key driver in HTLV-1-mediated leukemogenesis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 23, 2025
Peripheral Blood CD4/CD8 Ratio Predicts Out-of-Specification Products in Lisocabtagene Maraleucel Manufacturing.
Journal: Cancer reports (Hoboken, N.J.)
Published: June 04, 2025
Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy.
Journal: International journal of hematology
Published: May 28, 2025
Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.
Journal: Japanese journal of clinical oncology
Published: May 07, 2025
Last Updated: 09/26/2026